Gastrointestinal Endoscopy

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 24210 Experts worldwide ranked by ideXlab platform

Jeanmarc Dumonceau - One of the best experts on this subject based on the ideXlab platform.

  • reprocessing of flexible endoscopes and endoscopic accessories used in Gastrointestinal Endoscopy position statement of the european society of Gastrointestinal Endoscopy esge and european society of gastroenterology nurses and associates esgena upda
    Endoscopy, 2018
    Co-Authors: Ulrike Beilenhoff, Cesare Hassan, Jeanmarc Dumonceau, H Biering, R Blum, Jadranka Brljak, Monica Cimbro, Michael E Jung, Birgit Kampf, C S Neumann
    Abstract:

    This Position Statement from the European Society of Gastrointestinal Endoscopy (ESGE) and the European Society of Gastroenterology Nurses and Associates (ESGENA) sets standards for the reprocessing of flexible endoscopes and endoscopic devices used in gastroenterology. An expert working group of gastroenterologists, Endoscopy nurses, chemists, microbiologists, and industry representatives provides updated recommendations on all aspects of reprocessing in order to maintain hygiene and infection control.

  • pediatric Gastrointestinal Endoscopy european society of Gastrointestinal Endoscopy esge and european society for paediatric gastroenterology hepatology and nutrition espghan guideline executive summary
    Endoscopy, 2016
    Co-Authors: Andrea Tringali, Mike Thomson, Cesare Hassan, Jeanmarc Dumonceau, Marta Tavares, Merit M Tabbers, Raoul I Furlano, Manon C W Spaander, Christos Tzvinikos, Hanneke Ijsselstijn
    Abstract:

    This Executive summary of the Guideline on pediatric Gastrointestinal Endoscopy from the European Society of Gastrointestinal Endoscopy (ESGE) and the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) refers to infants, children, and adolescents aged 0 – 18 years. The areas covered include: indications for diagnostic and therapeutic esophagogastroduodenoscopy and ileocolonoscopy; Endoscopy for foreign body ingestion; endoscopic management of corrosive ingestion and stricture/stenosis; upper and lower Gastrointestinal bleeding; endoscopic retrograde cholangiopancreatography, and endoscopic ultrasonography. Percutaneous endoscopic gastrostomy and Endoscopy specific to inflammatory bowel disease (IBD) have been dealt with in other Guidelines and are therefore not mentioned in this Guideline. Training and ongoing skill maintenance will be addressed in an imminent sister publication.

  • self expandable metal stents for obstructing colonic and extracolonic cancer european society of Gastrointestinal Endoscopy esge clinical guideline
    Gastrointestinal Endoscopy, 2014
    Co-Authors: Jeanin E Van Hooft, Cesare Hassan, Jeanmarc Dumonceau, Emo E Van Halsema, Geoffroy Vanbiervliet, Regina G H Beetstan, John M Dewitt, Fergal Donnellan, R Glynnejones, Javier Jimenezperez
    Abstract:

    This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy (ESGE). This Guideline was also reviewed and endorsed by the Governing Board of the American Society for Gastrointestinal Endoscopy (ASGE). The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system was adopted to define the strength of recommendations and the quality of evidence. ESGE guidelines represent a consensus of best practice based on the available evidence at the time of preparation. They may not apply in all situations and should be interpreted in the light of specific clinical situations and resource availability. Further controlled clinical studies may be needed to clarify aspects of these statements, and revision may be necessary as new data appear. Clinical consideration may justify a course of action at variance to these recommendations. ESGE guidelines are intended to be an educational device to provide information that may assist endoscopists in providing care to patients. They are not rules and should not be construed as establishing a legal standard of care or as encouraging, advocating, requiring, or discouraging any particular treatment

  • self expandable metal stents for obstructing colonic and extracolonic cancer european society of Gastrointestinal Endoscopy esge clinical guideline
    Endoscopy, 2014
    Co-Authors: Jeanin E Van Hooft, Cesare Hassan, Jeanmarc Dumonceau, Emo E Van Halsema, Geoffroy Vanbiervliet, Regina G H Beetstan, John M Dewitt, Fergal Donnellan, R Glynnejones, Javier Jimenezperez
    Abstract:

    This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy (ESGE). This Guideline was also reviewed and endorsed by the Governing Board of the American Society for Gastrointestinal Endoscopy (ASGE). The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system was adopted to define the strength of recommendations and the quality of evidence. Main recommendations The following recommendations should only be applied after a thorough diagnostic evaluation including a contrast-enhanced computed tomography (CT) scan. 1 Prophylactic colonic stent placement is not recommended. Colonic stenting should be reserved for patients with clinical symptoms and imaging evidence of malignant large-bowel obstruction, without signs of perforation (strong recommendation, low quality evidence). 2 Colonic self-expandable metal stent (SEMS) placement as a bridge to elective surgery is not recommended as a standard treatment of symptomatic left-sided malignant colonic obstruction (strong recommendation, high quality evidence). 3 For patients with potentially curable but obstructing left-sided colonic cancer, stent placement may be considered as an alternative to emergency surgery in those who have an increased risk of postoperative mortality, I. e. American Society of Anesthesiologists (ASA) Physical Status ≥ III and/or age > 70 years (weak recommendation, low quality evidence). 4 SEMS placement is recommended as the preferred treatment for palliation of malignant colonic obstruction (strong recommendation, high quality evidence), except in patients treated or considered for treatment with antiangiogenic drugs (e. g. bevacizumab) (strong recommendation, low quality evidence).

  • european curriculum for sedation training in Gastrointestinal Endoscopy position statement of the european society of Gastrointestinal Endoscopy esge and european society of gastroenterology and Endoscopy nurses and associates esgena
    Endoscopy, 2013
    Co-Authors: Jeanmarc Dumonceau, Ulrike Beilenhoff, A Riphaus, Peter Vilmann, P Hornslet, Jose Ramon Aparicio, Mario Dinisribeiro, Emiliano Giostra, M Ortmann, J T A Knape
    Abstract:

    For more than 30 years, sedation using benzodiazepines, combined or not with opioids, has been used as a standard regimen for Gastrointestinal Endoscopy; it is usually referred to as traditional sedation. Sedation management in Gastrointestinal Endoscopy varies between European countries according to the different legal frameworks and different healthcare systems. In the majority of European countries, endoscopists administer sedation with support from Endoscopy nurses, while in some countries such as France only anesthesiologists administer intravenous sedation. In some countries any sedation can be administered by all trained clinicians, while in other countries administration of propofol can only be performed by anesthesiologists. Therefore, because of national legal restrictions, non-anesthesiologist administration of propofol (NAAP) has been established in only a few European countries, including Austria, Denmark, Germany, Greece, the Netherlands, Sweden, and Switzerland [1–9]. Irrespective of the type of sedation used, quality management requires pharmacologically appropriate training for all clinical staff involved in sedation practice. Individual qualifications, human resources and technical requirements have already been addressed in different guidelines [5, 10–17]. The German courses based on the national sedation curriculum combine sedation and emergency management, irrespective of the agent used for sedation (e.g., propofol, benzodiazepine, or combined medications) [18]. The nationwide implementation of these courses has significantly improved quality with regard to structure in German Gastrointestinal Endoscopy departments [19]. In Denmark, a training program for procedural sedation and analgesia (PSA) has been implemented in the capital region in cooperation with anesthesiologists [20]; sedation quality was found to be high following the implementation phase of NAAP in an Endoscopy suite [21]. Therefore common training practice standards for all methods of sedation used in Endoscopy have been shown to be beneficial in improving clinical practice as well as structural quality. European and national societies have already developed evidence-based and consensus-based guidelines for sedation and monitoring in Gastrointestinal Endoscopy that give a comprehensive outline of structural requirements, medication options, patient monitoring and discharge, and the role of Endoscopy staff [10–16]. Anesthesiology and gastroenterology societies have both demanded special training for staff administering sedation of any type [13,17], and especially for NAAP [10,14–16]. The joint endorsement of the present Curriculum by medical and nursing Endoscopy societies emphasizes that a multidisciplinary approach is the best response to current needs [13,15,16]. In the United States of America, a multisociety sedation curriculum for Gastrointestinal Endoscopy has recently been introduced [22]. The Curriculum presented here is based on the consensus of physicians (gastroenterologists, anesthesiologists) and nurses who have previously been involved in the development of European and national sedation guidelines for Endoscopy sedation, national curricula for Endoscopy sedation, and the organization of national and local courses for Endoscopy sedation.

Cesare Hassan - One of the best experts on this subject based on the ideXlab platform.

  • reprocessing of flexible endoscopes and endoscopic accessories used in Gastrointestinal Endoscopy position statement of the european society of Gastrointestinal Endoscopy esge and european society of gastroenterology nurses and associates esgena upda
    Endoscopy, 2018
    Co-Authors: Ulrike Beilenhoff, Cesare Hassan, Jeanmarc Dumonceau, H Biering, R Blum, Jadranka Brljak, Monica Cimbro, Michael E Jung, Birgit Kampf, C S Neumann
    Abstract:

    This Position Statement from the European Society of Gastrointestinal Endoscopy (ESGE) and the European Society of Gastroenterology Nurses and Associates (ESGENA) sets standards for the reprocessing of flexible endoscopes and endoscopic devices used in gastroenterology. An expert working group of gastroenterologists, Endoscopy nurses, chemists, microbiologists, and industry representatives provides updated recommendations on all aspects of reprocessing in order to maintain hygiene and infection control.

  • pediatric Gastrointestinal Endoscopy european society of Gastrointestinal Endoscopy esge and european society for paediatric gastroenterology hepatology and nutrition espghan guideline executive summary
    Endoscopy, 2016
    Co-Authors: Andrea Tringali, Mike Thomson, Cesare Hassan, Jeanmarc Dumonceau, Marta Tavares, Merit M Tabbers, Raoul I Furlano, Manon C W Spaander, Christos Tzvinikos, Hanneke Ijsselstijn
    Abstract:

    This Executive summary of the Guideline on pediatric Gastrointestinal Endoscopy from the European Society of Gastrointestinal Endoscopy (ESGE) and the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) refers to infants, children, and adolescents aged 0 – 18 years. The areas covered include: indications for diagnostic and therapeutic esophagogastroduodenoscopy and ileocolonoscopy; Endoscopy for foreign body ingestion; endoscopic management of corrosive ingestion and stricture/stenosis; upper and lower Gastrointestinal bleeding; endoscopic retrograde cholangiopancreatography, and endoscopic ultrasonography. Percutaneous endoscopic gastrostomy and Endoscopy specific to inflammatory bowel disease (IBD) have been dealt with in other Guidelines and are therefore not mentioned in this Guideline. Training and ongoing skill maintenance will be addressed in an imminent sister publication.

  • self expandable metal stents for obstructing colonic and extracolonic cancer european society of Gastrointestinal Endoscopy esge clinical guideline
    Gastrointestinal Endoscopy, 2014
    Co-Authors: Jeanin E Van Hooft, Cesare Hassan, Jeanmarc Dumonceau, Emo E Van Halsema, Geoffroy Vanbiervliet, Regina G H Beetstan, John M Dewitt, Fergal Donnellan, R Glynnejones, Javier Jimenezperez
    Abstract:

    This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy (ESGE). This Guideline was also reviewed and endorsed by the Governing Board of the American Society for Gastrointestinal Endoscopy (ASGE). The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system was adopted to define the strength of recommendations and the quality of evidence. ESGE guidelines represent a consensus of best practice based on the available evidence at the time of preparation. They may not apply in all situations and should be interpreted in the light of specific clinical situations and resource availability. Further controlled clinical studies may be needed to clarify aspects of these statements, and revision may be necessary as new data appear. Clinical consideration may justify a course of action at variance to these recommendations. ESGE guidelines are intended to be an educational device to provide information that may assist endoscopists in providing care to patients. They are not rules and should not be construed as establishing a legal standard of care or as encouraging, advocating, requiring, or discouraging any particular treatment

  • self expandable metal stents for obstructing colonic and extracolonic cancer european society of Gastrointestinal Endoscopy esge clinical guideline
    Endoscopy, 2014
    Co-Authors: Jeanin E Van Hooft, Cesare Hassan, Jeanmarc Dumonceau, Emo E Van Halsema, Geoffroy Vanbiervliet, Regina G H Beetstan, John M Dewitt, Fergal Donnellan, R Glynnejones, Javier Jimenezperez
    Abstract:

    This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy (ESGE). This Guideline was also reviewed and endorsed by the Governing Board of the American Society for Gastrointestinal Endoscopy (ASGE). The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system was adopted to define the strength of recommendations and the quality of evidence. Main recommendations The following recommendations should only be applied after a thorough diagnostic evaluation including a contrast-enhanced computed tomography (CT) scan. 1 Prophylactic colonic stent placement is not recommended. Colonic stenting should be reserved for patients with clinical symptoms and imaging evidence of malignant large-bowel obstruction, without signs of perforation (strong recommendation, low quality evidence). 2 Colonic self-expandable metal stent (SEMS) placement as a bridge to elective surgery is not recommended as a standard treatment of symptomatic left-sided malignant colonic obstruction (strong recommendation, high quality evidence). 3 For patients with potentially curable but obstructing left-sided colonic cancer, stent placement may be considered as an alternative to emergency surgery in those who have an increased risk of postoperative mortality, I. e. American Society of Anesthesiologists (ASA) Physical Status ≥ III and/or age > 70 years (weak recommendation, low quality evidence). 4 SEMS placement is recommended as the preferred treatment for palliation of malignant colonic obstruction (strong recommendation, high quality evidence), except in patients treated or considered for treatment with antiangiogenic drugs (e. g. bevacizumab) (strong recommendation, low quality evidence).

  • colon capsule Endoscopy european society of Gastrointestinal Endoscopy esge guideline
    Endoscopy, 2012
    Co-Authors: Cristiano Spada, Cesare Hassan, Jeanmarc Dumonceau, Samuel N Adler, Jean Paul Galmiche, Horst Neuhaus, O Epstein, Marco Pennazio, Douglas K Rex, R Benamouzig
    Abstract:

    PillCam colon capsule Endoscopy (CCE) is an innovative noninvasive, and painless ingestible capsule technique that allows exploration of the colon without the need for sedation and gas insufflation. Although it is already available in European and other countries, the clinical indications for CCE as well as the reporting and work-up of detected findings have not yet been standardized. The aim of this evidence-based and consensus-based guideline, commissioned by the European Society of Gastrointestinal Endoscopy (ESGE) is to furnish healthcare providers with a comprehensive framework for potential implementation of this technique in a clinical setting.

A Riphaus - One of the best experts on this subject based on the ideXlab platform.

  • european curriculum for sedation training in Gastrointestinal Endoscopy position statement of the european society of Gastrointestinal Endoscopy esge and european society of gastroenterology and Endoscopy nurses and associates esgena
    Endoscopy, 2013
    Co-Authors: Jeanmarc Dumonceau, Ulrike Beilenhoff, A Riphaus, Peter Vilmann, P Hornslet, Jose Ramon Aparicio, Mario Dinisribeiro, Emiliano Giostra, M Ortmann, J T A Knape
    Abstract:

    For more than 30 years, sedation using benzodiazepines, combined or not with opioids, has been used as a standard regimen for Gastrointestinal Endoscopy; it is usually referred to as traditional sedation. Sedation management in Gastrointestinal Endoscopy varies between European countries according to the different legal frameworks and different healthcare systems. In the majority of European countries, endoscopists administer sedation with support from Endoscopy nurses, while in some countries such as France only anesthesiologists administer intravenous sedation. In some countries any sedation can be administered by all trained clinicians, while in other countries administration of propofol can only be performed by anesthesiologists. Therefore, because of national legal restrictions, non-anesthesiologist administration of propofol (NAAP) has been established in only a few European countries, including Austria, Denmark, Germany, Greece, the Netherlands, Sweden, and Switzerland [1–9]. Irrespective of the type of sedation used, quality management requires pharmacologically appropriate training for all clinical staff involved in sedation practice. Individual qualifications, human resources and technical requirements have already been addressed in different guidelines [5, 10–17]. The German courses based on the national sedation curriculum combine sedation and emergency management, irrespective of the agent used for sedation (e.g., propofol, benzodiazepine, or combined medications) [18]. The nationwide implementation of these courses has significantly improved quality with regard to structure in German Gastrointestinal Endoscopy departments [19]. In Denmark, a training program for procedural sedation and analgesia (PSA) has been implemented in the capital region in cooperation with anesthesiologists [20]; sedation quality was found to be high following the implementation phase of NAAP in an Endoscopy suite [21]. Therefore common training practice standards for all methods of sedation used in Endoscopy have been shown to be beneficial in improving clinical practice as well as structural quality. European and national societies have already developed evidence-based and consensus-based guidelines for sedation and monitoring in Gastrointestinal Endoscopy that give a comprehensive outline of structural requirements, medication options, patient monitoring and discharge, and the role of Endoscopy staff [10–16]. Anesthesiology and gastroenterology societies have both demanded special training for staff administering sedation of any type [13,17], and especially for NAAP [10,14–16]. The joint endorsement of the present Curriculum by medical and nursing Endoscopy societies emphasizes that a multidisciplinary approach is the best response to current needs [13,15,16]. In the United States of America, a multisociety sedation curriculum for Gastrointestinal Endoscopy has recently been introduced [22]. The Curriculum presented here is based on the consensus of physicians (gastroenterologists, anesthesiologists) and nurses who have previously been involved in the development of European and national sedation guidelines for Endoscopy sedation, national curricula for Endoscopy sedation, and the organization of national and local courses for Endoscopy sedation.

  • european society of Gastrointestinal Endoscopy esge guideline development policy
    Endoscopy, 2012
    Co-Authors: Jeanmarc Dumonceau, Cesare Hassan, A Riphaus, T Ponchon
    Abstract:

    Numerous scientific publications explore the field of Gastrointestinal (GI) Endoscopy (a Pubmed search currently yields > 73000 results). Therefore, guidelines have become an indispensable tool for incorporating up-to-date knowledge into daily clinical care. Since the 1990 s, the issuing of guidelines has been a central task of the European Society of Gastrointestinal Endoscopy (ESGE). Here, the ESGE clarifies the types of policy documents that it issues and the methodology used to produce them, taking into account recent methodological developments.

  • european society of Gastrointestinal Endoscopy esge guideline development policy
    Endoscopy, 2012
    Co-Authors: Jeanmarc Dumonceau, Cesare Hassan, A Riphaus, T Ponchon
    Abstract:

    Numerous scientific publications explore the field of Gastrointestinal (GI) Endoscopy (a Pubmed search currently yields > 73000 results). Therefore, guidelines have become an indispensable tool for incorporating up-to-date knowledge into daily clinical care. Since the 1990 s, the issuing of guidelines has been a central task of the European Society of Gastrointestinal Endoscopy (ESGE). Here, the ESGE clarifies the types of policy documents that it issues and the methodology used to produce them, taking into account recent methodological developments.

  • european society of Gastrointestinal Endoscopy european society of gastroenterology and Endoscopy nurses and associates and the european society of anaesthesiology guideline non anaesthesiologist administration of propofol for gi Endoscopy
    European Journal of Anaesthesiology, 2010
    Co-Authors: Jeanmarc Dumonceau, Ulrike Beilenhoff, A Riphaus, Jose Ramon Aparicio, M Ortmann, J T A Knape, Gregorios A Paspatis, Cyriel Y Ponsioen, I Racz, F Schreiber
    Abstract:

    Propofol sedation by non-anaesthesiologists is an upcoming sedation regimen in several countries throughout Europe. Numerous studies have shown the efficacy and safety of this sedation regimen in Gastrointestinal Endoscopy. Nevertheless, this issue remains highly controversial. The aim of this evidence- and consensus-based set of guideline is to provide non-anaesthesiologists with a comprehensive framework for propofol sedation during digestive Endoscopy. This guideline results from a collaborative effort from representatives of the European Society of Gastrointestinal Endoscopy (ESGE), the European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) and the European Society of Anaesthesiology (ESA). These three societies have endorsed the present guideline.The guideline is published simultaneously in the Journals Endoscopy and European Journal of Anaesthesiology.

  • european society of Gastrointestinal Endoscopy european society of gastroenterology and Endoscopy nurses and associates and the european society of anaesthesiology guideline non anesthesiologist administration of propofol for gi Endoscopy
    Endoscopy, 2010
    Co-Authors: Jeanmarc Dumonceau, Ulrike Beilenhoff, A Riphaus, Jose Ramon Aparicio, M Ortmann, J T A Knape, Gregorios A Paspatis, Cyriel Y Ponsioen, I Racz, F Schreiber
    Abstract:

    Propofol sedation by non-anesthesiologists is an upcoming sedation regimen in several countries throughout Europe. Numerous studies have shown the efficacy and safety of this sedation regimen in Gastrointestinal Endoscopy. Nevertheless, this issue remains highly controversial. The aim of this evidence- and consensus-based set of guideline is to provide non-anesthesiologists with a comprehensive framework for propofol sedation during digestive Endoscopy. This guideline results from a collaborative effort from representatives of the European Society of Gastrointestinal Endoscopy (ESGE), the European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) and the European Society of Anaesthesiology (ESA). These three societies have endorsed the present guideline.

Javier Jimenezperez - One of the best experts on this subject based on the ideXlab platform.

  • self expandable metal stents for obstructing colonic and extracolonic cancer european society of Gastrointestinal Endoscopy esge clinical guideline
    Gastrointestinal Endoscopy, 2014
    Co-Authors: Jeanin E Van Hooft, Cesare Hassan, Jeanmarc Dumonceau, Emo E Van Halsema, Geoffroy Vanbiervliet, Regina G H Beetstan, John M Dewitt, Fergal Donnellan, R Glynnejones, Javier Jimenezperez
    Abstract:

    This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy (ESGE). This Guideline was also reviewed and endorsed by the Governing Board of the American Society for Gastrointestinal Endoscopy (ASGE). The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system was adopted to define the strength of recommendations and the quality of evidence. ESGE guidelines represent a consensus of best practice based on the available evidence at the time of preparation. They may not apply in all situations and should be interpreted in the light of specific clinical situations and resource availability. Further controlled clinical studies may be needed to clarify aspects of these statements, and revision may be necessary as new data appear. Clinical consideration may justify a course of action at variance to these recommendations. ESGE guidelines are intended to be an educational device to provide information that may assist endoscopists in providing care to patients. They are not rules and should not be construed as establishing a legal standard of care or as encouraging, advocating, requiring, or discouraging any particular treatment

  • self expandable metal stents for obstructing colonic and extracolonic cancer european society of Gastrointestinal Endoscopy esge clinical guideline
    Endoscopy, 2014
    Co-Authors: Jeanin E Van Hooft, Cesare Hassan, Jeanmarc Dumonceau, Emo E Van Halsema, Geoffroy Vanbiervliet, Regina G H Beetstan, John M Dewitt, Fergal Donnellan, R Glynnejones, Javier Jimenezperez
    Abstract:

    This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy (ESGE). This Guideline was also reviewed and endorsed by the Governing Board of the American Society for Gastrointestinal Endoscopy (ASGE). The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system was adopted to define the strength of recommendations and the quality of evidence. Main recommendations The following recommendations should only be applied after a thorough diagnostic evaluation including a contrast-enhanced computed tomography (CT) scan. 1 Prophylactic colonic stent placement is not recommended. Colonic stenting should be reserved for patients with clinical symptoms and imaging evidence of malignant large-bowel obstruction, without signs of perforation (strong recommendation, low quality evidence). 2 Colonic self-expandable metal stent (SEMS) placement as a bridge to elective surgery is not recommended as a standard treatment of symptomatic left-sided malignant colonic obstruction (strong recommendation, high quality evidence). 3 For patients with potentially curable but obstructing left-sided colonic cancer, stent placement may be considered as an alternative to emergency surgery in those who have an increased risk of postoperative mortality, I. e. American Society of Anesthesiologists (ASA) Physical Status ≥ III and/or age > 70 years (weak recommendation, low quality evidence). 4 SEMS placement is recommended as the preferred treatment for palliation of malignant colonic obstruction (strong recommendation, high quality evidence), except in patients treated or considered for treatment with antiangiogenic drugs (e. g. bevacizumab) (strong recommendation, low quality evidence).

Ulrike Beilenhoff - One of the best experts on this subject based on the ideXlab platform.

  • reprocessing of flexible endoscopes and endoscopic accessories used in Gastrointestinal Endoscopy position statement of the european society of Gastrointestinal Endoscopy esge and european society of gastroenterology nurses and associates esgena upda
    Endoscopy, 2018
    Co-Authors: Ulrike Beilenhoff, Cesare Hassan, Jeanmarc Dumonceau, H Biering, R Blum, Jadranka Brljak, Monica Cimbro, Michael E Jung, Birgit Kampf, C S Neumann
    Abstract:

    This Position Statement from the European Society of Gastrointestinal Endoscopy (ESGE) and the European Society of Gastroenterology Nurses and Associates (ESGENA) sets standards for the reprocessing of flexible endoscopes and endoscopic devices used in gastroenterology. An expert working group of gastroenterologists, Endoscopy nurses, chemists, microbiologists, and industry representatives provides updated recommendations on all aspects of reprocessing in order to maintain hygiene and infection control.

  • european curriculum for sedation training in Gastrointestinal Endoscopy position statement of the european society of Gastrointestinal Endoscopy esge and european society of gastroenterology and Endoscopy nurses and associates esgena
    Endoscopy, 2013
    Co-Authors: Jeanmarc Dumonceau, Ulrike Beilenhoff, A Riphaus, Peter Vilmann, P Hornslet, Jose Ramon Aparicio, Mario Dinisribeiro, Emiliano Giostra, M Ortmann, J T A Knape
    Abstract:

    For more than 30 years, sedation using benzodiazepines, combined or not with opioids, has been used as a standard regimen for Gastrointestinal Endoscopy; it is usually referred to as traditional sedation. Sedation management in Gastrointestinal Endoscopy varies between European countries according to the different legal frameworks and different healthcare systems. In the majority of European countries, endoscopists administer sedation with support from Endoscopy nurses, while in some countries such as France only anesthesiologists administer intravenous sedation. In some countries any sedation can be administered by all trained clinicians, while in other countries administration of propofol can only be performed by anesthesiologists. Therefore, because of national legal restrictions, non-anesthesiologist administration of propofol (NAAP) has been established in only a few European countries, including Austria, Denmark, Germany, Greece, the Netherlands, Sweden, and Switzerland [1–9]. Irrespective of the type of sedation used, quality management requires pharmacologically appropriate training for all clinical staff involved in sedation practice. Individual qualifications, human resources and technical requirements have already been addressed in different guidelines [5, 10–17]. The German courses based on the national sedation curriculum combine sedation and emergency management, irrespective of the agent used for sedation (e.g., propofol, benzodiazepine, or combined medications) [18]. The nationwide implementation of these courses has significantly improved quality with regard to structure in German Gastrointestinal Endoscopy departments [19]. In Denmark, a training program for procedural sedation and analgesia (PSA) has been implemented in the capital region in cooperation with anesthesiologists [20]; sedation quality was found to be high following the implementation phase of NAAP in an Endoscopy suite [21]. Therefore common training practice standards for all methods of sedation used in Endoscopy have been shown to be beneficial in improving clinical practice as well as structural quality. European and national societies have already developed evidence-based and consensus-based guidelines for sedation and monitoring in Gastrointestinal Endoscopy that give a comprehensive outline of structural requirements, medication options, patient monitoring and discharge, and the role of Endoscopy staff [10–16]. Anesthesiology and gastroenterology societies have both demanded special training for staff administering sedation of any type [13,17], and especially for NAAP [10,14–16]. The joint endorsement of the present Curriculum by medical and nursing Endoscopy societies emphasizes that a multidisciplinary approach is the best response to current needs [13,15,16]. In the United States of America, a multisociety sedation curriculum for Gastrointestinal Endoscopy has recently been introduced [22]. The Curriculum presented here is based on the consensus of physicians (gastroenterologists, anesthesiologists) and nurses who have previously been involved in the development of European and national sedation guidelines for Endoscopy sedation, national curricula for Endoscopy sedation, and the organization of national and local courses for Endoscopy sedation.

  • european society of Gastrointestinal Endoscopy european society of gastroenterology and Endoscopy nurses and associates and the european society of anaesthesiology guideline non anaesthesiologist administration of propofol for gi Endoscopy
    European Journal of Anaesthesiology, 2010
    Co-Authors: Jeanmarc Dumonceau, Ulrike Beilenhoff, A Riphaus, Jose Ramon Aparicio, M Ortmann, J T A Knape, Gregorios A Paspatis, Cyriel Y Ponsioen, I Racz, F Schreiber
    Abstract:

    Propofol sedation by non-anaesthesiologists is an upcoming sedation regimen in several countries throughout Europe. Numerous studies have shown the efficacy and safety of this sedation regimen in Gastrointestinal Endoscopy. Nevertheless, this issue remains highly controversial. The aim of this evidence- and consensus-based set of guideline is to provide non-anaesthesiologists with a comprehensive framework for propofol sedation during digestive Endoscopy. This guideline results from a collaborative effort from representatives of the European Society of Gastrointestinal Endoscopy (ESGE), the European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) and the European Society of Anaesthesiology (ESA). These three societies have endorsed the present guideline.The guideline is published simultaneously in the Journals Endoscopy and European Journal of Anaesthesiology.

  • european society of Gastrointestinal Endoscopy european society of gastroenterology and Endoscopy nurses and associates and the european society of anaesthesiology guideline non anesthesiologist administration of propofol for gi Endoscopy
    Endoscopy, 2010
    Co-Authors: Jeanmarc Dumonceau, Ulrike Beilenhoff, A Riphaus, Jose Ramon Aparicio, M Ortmann, J T A Knape, Gregorios A Paspatis, Cyriel Y Ponsioen, I Racz, F Schreiber
    Abstract:

    Propofol sedation by non-anesthesiologists is an upcoming sedation regimen in several countries throughout Europe. Numerous studies have shown the efficacy and safety of this sedation regimen in Gastrointestinal Endoscopy. Nevertheless, this issue remains highly controversial. The aim of this evidence- and consensus-based set of guideline is to provide non-anesthesiologists with a comprehensive framework for propofol sedation during digestive Endoscopy. This guideline results from a collaborative effort from representatives of the European Society of Gastrointestinal Endoscopy (ESGE), the European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) and the European Society of Anaesthesiology (ESA). These three societies have endorsed the present guideline.